Benefits of immediate complete revascularization in patients with acute coronary syndromes

Jacob J Elscot1, Hala Kakar1, Anniek C Ziedses DES Plantes1

  • 1Erasmus MC Cardiovascular Institute, Thorax Center, Department of Cardiology, Rotterdam, the Netherlands.

PubMed

Insights

Complete revascularization for acute coronary syndrome significantly reduces repeat heart attacks and procedures. This approach also leads to fewer stents and shorter hospital stays, improving patient outcomes.

Area of Science:

  • Cardiology
  • Interventional Cardiology

Background:

  • Acute coronary syndrome (ACS) is a major global cause of mortality.
  • A significant proportion of ACS patients have non-culprit lesions requiring attention.
  • Complete revascularization (CR) is recommended for all significant lesions.

Purpose of the Study:

  • To evaluate the benefits of immediate complete multivessel percutaneous coronary intervention in a single setting for ACS patients.
  • To compare immediate CR with other revascularization strategies.

Main Methods:

  • Review of recent randomized trials comparing immediate complete multivessel percutaneous coronary intervention with other approaches.
  • Analysis of outcomes including repeat myocardial infarction, unplanned revascularization, stent usage, contrast volume, and hospitalization duration.

Main Results:

  • Immediate CR is linked to a lower risk of recurrent myocardial infarction and ischemia-driven revascularization.
  • Immediate CR resulted in fewer implanted stents, reduced contrast usage, and shorter hospital stays.
  • The success rate of complete revascularization was maintained.

Conclusions:

  • Performing complete multivessel percutaneous coronary intervention in a single setting offers significant advantages for ACS patients.
  • Further research is needed on the role of coronary physiology and intravascular imaging in understanding non-culprit lesion pathophysiology.

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...